Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies.
about
The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide AnalogsAntiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virusTransfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.Therapeutic management of hepatitis B-related cirrhosis.Efficient pyrophosphorolysis by a hepatitis B virus polymerase may be a primer-unblocking mechanism.The analysis of correlation between IL-12 gene expression and hepatitis B virus in the affected patients.Inhibition of hepatitis B virus by a novel L-nucleoside, beta-L-D4A and related analogues.Lethiferous effects of a recombinant vector carrying thymidine kinase suicide gene on 2.2.15 cells via a self-modulating mechanism.Expression of hepatitis B virus 1.3-fold genome plasmid in an SV40 T-antigen-immortalized mouse hepatic cell line.Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen.Fidelity of hepatitis B virus polymerase.Inhibition of hepadnaviral replication by polyethylenimine-based intravenous delivery of antisense phosphodiester oligodeoxynucleotides to the liver.Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.Prevalence and clinical correlates of YMDD variants during lamivudine therapy for patients with chronic hepatitis B.Clinical evaluation of oligonucleotide microarrays for the detection of HBV mutants associated with lamivudine resistance.
P2860
Q26781795-BA8068A5-9688-49C9-A17E-D42F47E9844FQ28360714-48C7235A-B324-470C-81A0-0005CBAF5F1CQ33851759-5B82CE6F-8A15-46AF-892B-226F7D85CF5CQ34434784-63FD111E-F998-44F8-81D9-C3A1EF0AF434Q35859634-2173DEDE-CFC6-457B-9BEB-CE588E852DF9Q36064368-CE079830-F1B9-46D2-B144-EDAD07486560Q36178977-5022BD2D-50EA-4D51-976D-F297702D0C95Q36308663-D5481920-DCA2-43D4-91DE-F3A771042998Q37358636-FF686495-9D06-4EC8-9A88-D89DBE6D8C36Q39593181-2158A90E-340B-489C-A527-1FBD8297A91CQ42047382-04EFDBBA-BCF9-494D-84FE-533C9C4E4AD6Q43652182-97E7EC71-5D5D-4BBA-AB67-3A4D6AF52031Q44282613-19A3C319-3E94-4488-8DD8-9E611EE2B301Q44355905-D4F4C29C-3F85-4C36-9DC8-08CC42B9F362Q46737654-9BC8155F-9CD7-4F32-834F-25A981EEC38A
P2860
Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Therapy of chronic hepatitis B ...... nd other antiviral strategies.
@ast
Therapy of chronic hepatitis B ...... nd other antiviral strategies.
@en
type
label
Therapy of chronic hepatitis B ...... nd other antiviral strategies.
@ast
Therapy of chronic hepatitis B ...... nd other antiviral strategies.
@en
prefLabel
Therapy of chronic hepatitis B ...... nd other antiviral strategies.
@ast
Therapy of chronic hepatitis B ...... nd other antiviral strategies.
@en
P1433
P1476
Therapy of chronic hepatitis B ...... nd other antiviral strategies.
@en
P2093
P356
10.1016/S0166-3542(99)00056-X
P577
1999-11-01T00:00:00Z